Investor Relations

Investment Overview

CBMG's goal is to develop safe and effective cellular medicine therapies for indications that represent a large unmet medical need in China and the US.


Investment Highlights

  • 01

    Excellence in Cell Therapy Recognized by 2 Global Pharma

  • 02

    Systematic Approach and Highly Differentiated Pipeline

  • 03

    End-to-end R&D and CMC Capabilities

  • 04

    Lower valuation than peers given development progress, growth catalysts and addressable market size.

  • 05

    Top Notch Leadership Backed by MNCs and Renowned Investors

  • 06

    Assets with first-to-market & best-in-class potentials

Our strategy is to commercialize both home grown and partnered cellular medicine technologies in a safe and efficient manner